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Letters to the Editorgeneralizability of the study. More im-
portantly, however, they prevent full
consideration of all relevant available
evidence. A PubMed search reveals 6
randomized, controlled trials compar-
ing the patency of RA and SV conduits,
but only 5 (or more accurately 4 sepa-
rate article) were included in this study.
Furthermore, no justification was given
for ignoring the 36 nonrandomized
studies that have compared many thou-
sands of angiograms. Because all rele-
vant studies were not included, several
clinically important variables were not
examined, such as long-term (>5 years)
conduit patency, which is a more rele-
vant end point when selecting revascu-
larization strategy than is the 22-
month mean angiographic follow-up
reported.1
Closer inspection of the extracted
data, discussion, and study methodol-
ogy reveals several critical flaws that
compromise the study findings. The
correct observational long-term pa-
tency data of the RAPCO (Radial
Artery Patency and Clinical Outcome)
trial can be found in a later article
authored by Hayward and associates2
(angiographic follow-up time 60
months, RA patency 89.1%, SV pa-
tency 82.4%), but Benedetto and
colleagues1 selected an earlier report,
possibly because they focused on fail-
ure rate rather than patency. Metare-
gression of only 5 studies is flawed
for several statistical reasons.3 Bene-
detto and colleagues1 have concluded
on the basis of results with unknown
heterogeneity that patency is compara-
ble between RA and SV conduits and
that the time of follow-up does not
affect the accuracy of the overall esti-
mate of patency. These conclusions
are not possible unless early, midterm,
and long-term patencies have been
examined in a stratified manner,
because different mechanisms are
responsible for graft failure at different
time horizons. Other sources of hetero-
geneity, for example the quality of
reporting of the angiographic patency,
do not appear to have been investi-
gated. Although the authors stated1670 The Journal of Thoracic andthat I2 was calculated, this value was
not reported.
The flawed methodology, results,
and conclusions of this study have in-
troduced an even more distorted view
of the existing evidence. Benedetto
and colleagues assessed the literature
through a key hole and consequently
cannot see the evidence horizon. This
perspective misinforms clinical deci-
sion making and misguides the focus
of future research. This article is an
example of fast-track publication of
a poorly conducted meta-analysis
without consideration of the potential
causes of heterogeneity and without
taking into account characteristics of
angiographic patency that justify its
use as a surrogate outcome.
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doi:10.1016/j.jtcvs.2009.12.049Reply to the Editor:
We would like to underline some
fundamental issues concerning meta-
analyses that Athanasiou and col-
leagues seem to have forgotten in their
letter.Cardiovascular Surgery c June 2010First, in cardiac surgery, as in other
clinical fields, conclusive evidence
should be addressed by the analysis
of randomized, controlled trials
(RCTs) when available. Observational
studies frequently reach distorted con-
clusions because they are influenced
by confounding. For example, no
RCT has ever confirmed the benefits
of beating-heart coronary surgery
implied by observational studies.1
In addition, graft failure is an out-
come strongly influenced by the qual-
ity of target vessels.2 It is reasonable
to suppose that in clinical practice, ra-
dial artery conduits have been used for
good quality target vessels, whereas
saphenous vein grafts have been used
on poorer quality vessels to complete
revascularization. This concern in
observational cohorts may not confi-
dently be controlled for by any risk
adjusted-analysis but is completely
eliminated by randomization. There-
fore for this topic, RCTs, even with
their limitations, are largely better
than any observational cohort study.
Even a keyhole is preferable to a black
hole. There is thus no reason to con-
duct a meta-analysis on observational
distorted results when several RCTs
are fortunately available. Despite these
considerations, Athanasiou and col-
leagues love to read and publish
meta-analyses of nonrandomized com-
parative studies, even when a large
body of RCTs is available. They there-
fore reach conclusions3 completely
discordant with RCTs,4 and it is hard
to justify the exceptions made for se-
lection bias related to nonrandomized
design.
Second, the Editor of this Journal is
interested in brief contributions. As
stated in the Information for Authors,
brief communications provide an op-
tion to have an article published in
a more rapid fashion. Therefore our
work is not an example of fast-track
publication but rather is in line with
the policy of this Journal. As Athana-
siou and colleagues can see, several
meta-analyses of RCTs on different
topics in cardiac surgery are published
Letters to the Editorin the Brief Research Reports section
of this Journal. Because such brief
communications should contain no
more than 750 words, we could not
report all aspects of our literature
research, statistical analysis, results,
considerations, and conclusions. Re-
viewers and editors, however, found
our work to be worthy of publication.
Are Athanasiou and colleagues per-
haps complaining about the ability of
the Editor or reviewers of this Jour-
nal? Is one of them suggesting himself
as the new Editor of this Journal?
Athanasiou and colleagues will be
astonished to read that our conclusions
are supported and confirmed in a Letter
to the Editor from Takagi and associ-
ates,5 which is an update to our work.
Is even Takagi’s work an example of
fast-track publication of a poorly con-
ducted meta-analysis? Are Athanasiou
and colleagues the only researchers
who can publish reliable meta-analy-
ses?
Looking to an another ‘‘evidence
horizon,’’ meta-analysis and system-
atic review of non-RCTs by Athana-
siou and colleagues have encouraged
the use of minimally invasive great sa-
phenous vein harvesting in coronary
artery bypass grafting.6 These conclu-
sions have been strongly disputed by
a recent very large study published in
the New England Journal of Medicine.
Sometime, even a great researcher
looks into a black hole.7
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To the Editor:
We readwith great interest the article
by Benedetto and associates.1 In their
meta-analysis of 5 randomized, con-
trolled trials, they demonstrated no sig-
nificant advantage of radial artery (RA)
relative to saphenous vein graft (SVG)
conduits in coronary artery bypass
grafting for ‘‘graft failure’’ including
‘‘total occlusion’’ and ‘‘string sign’’
(random-effects risk difference [RD],
0.40; 95% confidence interval [CI],
0.128 to 0.048; P ¼ .372). More
recently, however, Hayward and col-
laborators2 updated the results of the
Radial Artery Patency and Clinical
Outcomes (RAPCO) trial that were
originally reported by Buxton and col-
leagues3 in 2003. We performed an
updated meta-analysis of randomized,
controlled trials ofRAversus SVGcon-
duits in coronary artery bypass grafting
for ‘‘total occlusion,’’ ‘‘string sign,’’
and ‘‘graft failure’’ (‘‘total occlusion’’
plus ‘‘string sign’’).of Thoracic and Cardiovascular SurgerAlthoughBuxton and colleagues3 es-
timated graft patency in only 24RA and
22 SVG conduits in the RAPCO trial,
Hayward and collaborators2 performed
protocol angiography in 53 patients as-
signed to receive RA conduits and 60
patients assigned to receive SVG con-
duits at mean follow-up of 5.5 years.
In total, our meta-analysis included
data on 1176 grafts (592 RA and 584
SVG). Pooled analysis of the 5 trials, in-
cluding updated results2 of the RAPCO
trial, demonstrated a statistically signif-
icant reduction in ‘‘total occlusion’’
(random-effects RD, 0.07; 95% CI,
0.12 to0.03; P ¼ .0009; Figure 1,
A) but a statistically significant increase
in ‘‘string sign’’ (random-effects RD,
0.04; 95% CI, 0.02 to 0.07; P ¼
.0002; Figure 1, B) with RA relative to
SVG, resulting in a statistically nonsig-
nificant reduction in ‘‘graft failure’’
(‘‘total occlusion’’ plus ‘‘string sign,’’
random-effects RD, 0.05; 95% CI,
0.13 to 0.02; P ¼ .16; Figure 1, C).
Sensitivity analyses were performed to
assess the contribution of each study to
the pooled estimate by excluding indi-
vidual trials one at a time and recalculat-
ing the pooled RD estimates for the
remaining studies. Exclusion of any sin-
gle trial from the analysis of ‘‘total oc-
clusion’’ did not substantively alter the
overall result of our analysis. Although
elimination of any single trial except
for the Radial Artery Patency Study
(RAPS)4 from the analysis of ‘‘string
sign’’ did not substantially change the
pooled estimate, exclusion of the
RAPS, which included the largest num-
ber of grafts, demonstrated a statistically
nonsignificant increase in ‘‘string sign’’
(random-effects RD, 0.02; 95% CI,
0.02 to 0.05;P¼ .30)with RA relative
to SVG. Although elimination of any
single trial except for the RAPS4 from
the analysis of ‘‘graft failure’’ (‘‘total
occlusion’’ plus ‘‘string sign’’) did not
substantially change the pooled esti-
mate, exclusion of the RAPS demon-
strated a statistically significant
reduction in ‘‘graft failure’’ (random-ef-
fects RD,0.09; 95%CI,0.17 to 0.00;
P ¼ .04) with the RA relative to SVG.y c Volume 139, Number 6 1671
